PaxMedica (PXMD) Competitors

PaxMedica (NASDAQ:PXMD) and Evelo Biosciences (NASDAQ:EVLO) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, valuation, earnings, risk and dividends.

Is PXMD or EVLO more profitable?

Evelo Biosciences' return on equity of 0.00% beat PaxMedica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PaxMedica	N/A	-3,167.89%	-560.35%
Evelo Biosciences	N/A	N/A	N/A

Does the media favor PXMD or EVLO?

In the previous week, Evelo Biosciences' average media sentiment score of 0.32 beat PaxMedica's score of 0.00 indicating that Evelo Biosciences is being referred to more favorably in the news media.

Company	Overall Sentiment
PaxMedica	Neutral
Evelo Biosciences	Neutral

Which has better valuation & earnings, PXMD or EVLO?

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PaxMedica	N/A	N/A	-$18.29M	N/A	N/A
Evelo Biosciences	N/A	N/A	-$114.53M	N/A	N/A

Do insiders and institutionals have more ownership in PXMD or EVLO?

4.9% of PaxMedica shares are held by institutional investors. Comparatively, 0.3% of Evelo Biosciences shares are held by institutional investors. 1.0% of PaxMedica shares are held by insiders. Comparatively, 1.0% of Evelo Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Which has more volatility and risk, PXMD or EVLO?

PaxMedica has a beta of -0.99, indicating that its stock price is 199% less volatile than the S&P 500. Comparatively, Evelo Biosciences has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500.

Summary

Evelo Biosciences beats PaxMedica on 5 of the 7 factors compared between the two stocks.